毒素A型治疗是否会影响宫性 dystonia 患者的非运动症状? 一个系统的审查
Małgorzata Dudzic1, Anna Pieczyńska2, Artur Drużdż3
1Department of Neurology, Municipal Hospital in Poznan, Poland. gosiadudzic@gmail.com.
Neurologia i neurochirurgia polska
|February 14, 2025
概括
毒素A (BoNTA) 显著改善了宫 dystonia 患者的抑郁和焦虑. 然而,它对睡眠障碍的影响需要进一步研究,强调需要全面的治疗策略.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 宫性 dystonia 由于非运动症状 (NMS) 显著影响生活质量.
- 毒素A (BoNTA) 对于运动症状是有效的,但其NMS效应的理解较少.
- 像抑郁症,焦虑症和睡眠障碍这样的NMS在宫 dystonia中很常见.
研究的目的:
- 系统地审查BoNTA对抑郁症,焦虑症和宫 dystonia 睡眠障碍的影响的证据.
- 综合当前关于BoNTA对特定非运动症状的影响的研究结果.
- 确定关于BoNTA对NMS的疗效的知识差距.
主要方法:
- 对PubMed,Web of Science和Scopus数据库进行系统审查.
- 包括8项符合严格标准的研究从266个已识别的文章中.
- 对280名成年患者的NMS干预前后变化的评估.
主要成果:
- 博恩塔对抑郁症状产生了积极影响,大多数研究报告了统计学上显著的改善.
- 在接受BoNTA治疗后,观察到焦虑得分显著降低.
- 对睡眠障碍的影响是不确定的,睡眠质量或白天嗜睡没有显著改善.
结论:
- 博恩塔在改善宫 dystonia 患者的抑郁和焦虑方面显示出潜力.
- 博恩塔对睡眠障碍的影响尚不清楚,需要进一步研究.
- 需要进一步研究,以了解NMS的机制,并制定NMS的综合治疗策略.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
650
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
650
Skeletal Muscle Relaxants: Therapeutic Uses
460
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
460
Skeletal Muscle Relaxants: Adverse Effects
330
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
330
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
385
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
385


